Chemistry synthesis innovator Syrris has revealed that interest in its new flow chemistry (FRX) and Atlas synthesis systems has been so high that it is now doubling its sales force
Since the launch of the FRX and Atlas in late 2006, Syrris has delivered systems to major pharma companies and academic institutions throughout Europe and the USA.
Commenting on the news Syrris's commercial director, Richard Gray, said "We are extremely pleased with the interest in these products so far.
"I think the key to their success has been their flexibility and simplicity.
"They are designed to accommodate a broad spectrum of applications and needs within the chemistry laboratory, and can be scaled up as requirements change.
"The systems overcome present day challenges such as process repeatability and laboratory efficiency, while remaining incredibly easy to use".
Both the FRX and Atlas are modular, allowing chemists to select the system that best suits their individual needs.
The FRX is a flow chemistry system available in four models, covering a range of functionalities.
Reactions occur under laminar flow conditions, improving reaction speed, optimisation and control, but additionally the FRX allows both solid- and solution-phase chemistry to be performed.
The Atlas system was developed as a highly modular multipurpose synthesis tool.
Cost-effective and easy to use, Atlas offers an automation for a variety of applications including heating, stirring, cooling and automated reagent addition.
Additionally, Atlas can be used as a stand-alone unit, connected in parallel or with PC control.
With medicinal chemists increasingly moving to Syrris's new modular chemistry systems, Syrris is doubling its current sales force and is also appointing distributors to cover India (Nuilab Equipment), Japan (Hansen), Italy (Stepbio) and Australia (John Morris).
